doi:10.1089/thy.2004.14.1047 [11] Grtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW
[DOI] [PMC free article] [PubMed] [Google Scholar] 58.Damgaard R.B
Some people taking these medications also experienced weight loss, which has led to widespread interest
For a 1:1 combo, every draw contains equal parts of both compounds
Nature 619 , 371377 (2023)
Additional at-risk groups include: Vegans and strict vegetarians , who may have low dietary B12 intake People with autoimmune conditions , including pernicious anaemia or type 1 diabetes Individuals with gastrointestinal conditions such as Crohn's disease or coeliac disease, which impair nutrient absorption People who have undergone bariatric surgery , which can significantly reduce B12 absorption Long-term users of proton pump inhibitors (PPIs) or H2-receptor antagonists , which reduce gastric acid and impair B12 release from food Those with a family history of either pernicious anaemia or diabetes For these groups, simultaneous monitoring of B12 status and glycaemic markers is particularly important to avoid diagnostic errors
